If you have glaucoma and are considering cataract surgery, you may be a candidate for the COMPASS Clinical Study. The study is evaluating the CyPass® Micro-Stent
– an investigational device designed for open angle glaucoma. The CyPass Micro-Stent is placed during routine cataract surgery, and may offer an alternative to your current glaucoma treatment. The COMPASS study is currently being offered at several specialized ophthalmology centers throughout the U.S.
The CyCLE study is being conducted in several sites throughout Europe to further demonstrate the safety and efficacy of the CyPass Micro-Stent in patients with glaucoma.
The DUETTE study is focused on evaluating the safety and efficacy of the CyPass Micro-Stent as a stand-alone therapy in patients on glaucoma eyedrop medications.